Carlos Grijalva
Last active: 7/27/2018

  1. A household-based study of contact networks relevant for the spread of infectious diseases in the highlands of Peru. Grijalva CG, Goeyvaerts N, Verastegui H, Edwards KM, Gil AI, Lanata CF, Hens N, RESPIRA PERU project (2015) PLoS One 10(3): e0118457
    › Primary publication · 25734772 (PubMed) · PMC4348542 (PubMed Central)
  2. Thiazolidinedione and Metformin Use and the Risk of Benign Prostate Hyperplasia in Veterans with Diabetes Mellitus. Murff HJ, Roumie CL, Greevy RA, Grijalva CG, Hung AH, Liu X, Griffin MR (2014) J Mens Health 11(4): 157-162
    › Primary publication · 25798210 (PubMed) · PMC4364420 (PubMed Central)
  3. The role of influenza and parainfluenza infections in nasopharyngeal pneumococcal acquisition among young children. Grijalva CG, Griffin MR, Edwards KM, Williams JV, Gil AI, Verastegui H, Hartinger SM, Vidal JE, Klugman KP, Lanata CF (2014) Clin Infect Dis 58(10): 1369-76
    › Primary publication · 24621951 (PubMed) · PMC4001292 (PubMed Central)
  4. The high burden of pneumonia on US emergency departments during the 2009 influenza pandemic. Self WH, Griffin MR, Zhu Y, Dupont WD, Barrett TW, Grijalva CG (2014) J Infect 68(2): 156-64
    › Primary publication · 24140066 (PubMed) · PMC3947237 (PubMed Central)
  5. Reducing blood culture contamination in community hospital emergency departments: a multicenter evaluation of a quality improvement intervention. Self WH, Mickanin J, Grijalva CG, Grant FH, Henderson MC, Corley G, Blaschke Ii DG, McNaughton CD, Barrett TW, Talbot TR, Paul BR (2014) Acad Emerg Med 21(3): 274-82
    › Primary publication · 24628752 (PubMed) · PMC3984048 (PubMed Central)
  6. Readmissions among children previously hospitalized with pneumonia. Neuman MI, Hall M, Gay JC, Blaschke AJ, Williams DJ, Parikh K, Hersh AL, Brogan TV, Gerber JS, Grijalva CG, Shah SS (2014) Pediatrics 134(1): 100-9
    › Primary publication · 24958590 (PubMed) · PMC4531280 (PubMed Central)
  7. Prevention of invasive pneumococcal diseases: beyond cultures. Grijalva CG, Griffin MR (2014) Lancet Respir Med 2(9): 676-7
    › Primary publication · 25127243 (PubMed) · PMC4820063 (PubMed Central)
  8. Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) study. Baddley JW, Winthrop KL, Chen L, Liu L, Grijalva CG, Delzell E, Beukelman T, Patkar NM, Xie F, Saag KG, Herrinton LJ, Solomon DH, Lewis JD, Curtis JR (2014) Ann Rheum Dis 73(11): 1942-8
    › Primary publication · 23852763 (PubMed) · PMC4273901 (PubMed Central)
  9. Impact of home environment interventions on the risk of influenza-associated ARI in Andean children: observations from a prospective household-based cohort study. Budge PJ, Griffin MR, Edwards KM, Williams JV, Verastegui H, Hartinger SM, Mäusezahl D, Johnson M, Klemenc JM, Zhu Y, Gil AI, Lanata CF, Grigalva CG, RESPIRA PERU Group (2014) PLoS One 9(3): e91247
    › Primary publication · 24622044 (PubMed) · PMC3951509 (PubMed Central)
  10. Decrease in antibiotic use, an added benefit of PCVs. Grijalva CG (2014) Lancet Infect Dis 14(3): 175-7
    › Primary publication · 24287185 (PubMed) · PMC4831623 (PubMed Central)